Industry News
Eiffel to focus on developing inhaled and transdermal insulin
Eiffel Technologies (ASX : EIF) announced today it has completed further animal studies in its development of improved injectable insulin, and would focus resources on collaborations with pharmaceutical companies working on inhaled or transdermal insulin. [ + ]
QRxPharma's opioid greater than the sum of its parts
Minimising the side-effects that plague patients taking opioid pain-relievers will be the big advantage of Queensland-based QRxPharma’s novel opioid candidate Q8003, according to Alex Baker, Program Manager at QRxPharma. [ + ]
Growing replacement organs organically
Australian scientists believe it may be possible to grow replacement organs organically, by providing organ-building stem cells with a 3-D template and leaving them to grow in situ, within the patient’s own body. [ + ]
Southpoint acquires Boron molecular
Former Perth-based telecommunications company Southpointe (ASX: SOU) plans to become a biotechnology investment company after acquiring interests in two biotechnology-related ventures. [ + ]
VRI to raise $2.9 million
VRI Biomedical has announced plans to raise up to AUD$2.9 million through a just completed share placement and a non-renounceable rights issue to be put towards production and marketing of the company's proTract probiotic products. [ + ]
Research agencies face funding shake-up
CSIRO, the Australian Institute for Marine Science, and other publicly funded research agencies (PRFAs) may be in for a funding shake-up, following the release of the Research Collaboration Review by Federal Minister for Education, Science and Training Brendan Nelson last week. [ + ]
Gradipore changes name to Life Therapeutics
Gradipore (ASX: GDP) has changed its name to Life Therapeutics to reflect its new strategy, the company announced today. [ + ]
Award for Nulka Designer
Melbourne flight control systems specialist, Mal Crozier, from BAE Systems Australia has been officially recognised for his work in developing Nulka Missile Decoy system.
[ + ]GTG awarded further patents and forensic accreditation
Genetic Technologies' (ASX: GTG) non-coding DNA analysis and foetal cell separation patents have been allowed by the Canadian Patent Office -- almost 15 years after the company filed its first non-coding DNA patent. [ + ]
Ballard wins Clunies Ross award
South Australian biotechnologist Dr John Ballard has been awarded an ATSE Clunies Ross Award in recognition of his achievements in biochemical drug development over the course of his career, which has included starting three biotechnology companies, and more recently an investment organisation, BioAngels. [ + ]
Bionomics files patent on angiogenesis gene trove
Adelaide-based meditech Bionomics LIMITED (ASX:BNO, US OTC:BMICY) has filed another international patent application on 496 potential gene targets for angiogenesis-inhibiting drugs. [ + ]
A life of Turbulence Rewarded
The University of Newcastle's Professor Robert Antonia, from the Faculty of Engineering and Built Environment, is considered a leading authority on turbulence.
[ + ]China OKs Brazil GMO soybean imports
China approved the importation of genetically modified soybeans from Brazil, which should allow shipments to begin as early as Tuesday for the world's largest soybean importer, according to Brazil's Agriculture Ministry. [ + ]
Virax raises $3.7 million in placement
Virax (ASX: VHL) announced this week that it had raised AUD$3.7 million through a placement to institutional and professional investors. [ + ]
Cogstate licences angiotensin compounds for Alzheimers
Recently listed company CogState (ASX: CGS) has signed a licensing and research collaboration deal with Pacific Northwest Biotechnology (PNB) in the US to develop a drug to treat Alzheimer's disease. [ + ]
